By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


Company News
Hemispherx (HEB) Retains Huron Consulting Group To Support Partnering Strategy And Planning For Alferon And Ampligen 4/20/2016 9:50:04 AM
Ousted Hemispherx (HEB) CEO Files Lawsuit, Seeks $1 Million+ Wages and Bonuses He's Allegedly Owes 4/1/2016 6:22:46 AM
Hemispherx (HEB) Announces Financial Results For The Year Ended December 31, 2015 3/30/2016 10:19:16 AM
Hemispherx (HEB) Announces Conference Call To Discuss Management Changes And Provide Corporate Update On March 30, 2016 3/22/2016 8:30:59 AM
New Hemispherx (HEB) CEO Will Not Receive Salary for Two Months Until Stock Performs Better 3/11/2016 6:32:09 AM
Hemispherx (HEB) Reviews Ampligen Data With National Institute Of Neurological Disorders 3/10/2016 8:09:52 AM
Hemispherx (HEB) Shakes Up Executive Management Team After Terminating Longtime CEO Last Week 2/22/2016 7:55:06 AM
Hemispherx (HEB) Fires CEO Following Reexamination of Priorities, Implements Ant-Nepotism Policy 2/19/2016 6:39:12 AM
Hemispherx (HEB) Exploring Possible Research Programs In Zika Virus Modeled On A Prior Alferon N Clinical Trial On Closely Related Flavivirus (West Nile) 2/9/2016 7:55:47 AM
Hemispherx (HEB) Introduces A Voluntary Stock Purchase Plan To Create Shareholder Value 2/3/2016 8:09:39 AM